T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Elevance Health
ELV
|
+$1.16B |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$1.01B |
| 4 |
Royal Caribbean
RCL
|
+$860M |
| 5 |
AET
Aetna Inc
AET
|
+$790M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.76B |
| 2 |
Biogen
BIIB
|
+$1.47B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.26B |
| 4 |
McKesson
MCK
|
+$1.2B |
| 5 |
Sherwin-Williams
SHW
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.75% |
| 2 | Consumer Discretionary | 14.84% |
| 3 | Financials | 13.9% |
| 4 | Technology | 11.11% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
iShares MSCI Japan ETF
EWJ
$23.2B
| $773K | ﹤0.01% |
16,900
-750
| -4% | -$37K |
|
|
RPAI
1777
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $772K | ﹤0.01% |
54,800
| – | – |
|
1778
Apple Hospitality REIT
APLE
$3.75B
| $771K | ﹤0.01% |
+41,500
| New | +$759K |
|
1779
Invesco Mortgage Capital
IVR
$805M
| $769K | ﹤0.01% |
6,280
| – | – |
|
1780
Integra LifeSciences
IART
$1.42B
| $768K | ﹤0.01% |
25,800
-5,759
| -18% | -$180K |
|
1781
Cinemark Holdings
CNK
$4.37B
| $767K | ﹤0.01% |
23,600
+1,900
| +9% | +$70.7K |
|
1782
Hyatt Hotels
H
$16.9B
| $763K | ﹤0.01% |
16,200
-1,400
| -8% | -$74.7K |
|
1783
Sanmina
SANM
$11.1B
| $762K | ﹤0.01% |
35,652
+3,400
| +11% | +$68.6K |
|
|
HRC
1784
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $762K | ﹤0.01% |
14,650
| – | – |
|
1785
Axos Financial
AX
$5.72B
| $760K | ﹤0.01% |
23,600
+7,600
| +48% | +$227K |
|
1786
American Homes 4 Rent
AMH
$12.3B
| $756K | ﹤0.01% |
47,000
| – | – |
|
1787
TC Energy
TRP
$65.8B
| $752K | ﹤0.01% |
23,900
+2,100
| +10% | +$75.4K |
|
|
VRNT
1788
DELISTED
Verint Systems
VRNT
| $751K | ﹤0.01% |
34,156
| – | – |
|
1789
Leidos
LDOS
$17.9B
| $748K | ﹤0.01% |
18,100
| – | – |
|
1790
Delek US
DK
$4.18B
| $745K | ﹤0.01% |
26,900
+2,000
| +8% | +$67.2K |
|
|
CNCE
1791
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $745K | ﹤0.01% |
+39,705
| New | +$675K |
|
|
CNSL
1792
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $730K | ﹤0.01% |
37,892
| – | – |
|
|
LXK
1793
DELISTED
Lexmark Intl Inc
LXK
| $727K | ﹤0.01% |
25,100
| – | – |
|
1794
Babcock & Wilcox
BW
$1.39B
| $726K | ﹤0.01% |
+4,324
| New | +$798K |
|
|
TEF
1795
DELISTED
Telefonica
TEF
| $722K | ﹤0.01% |
79,420
+5,167
| +7% | +$55K |
|
1796
MBIA
MBI
$262M
| $718K | ﹤0.01% |
118,050
-802,200
| -87% | -$5.16M |
|
1797
Insight Enterprises
NSIT
$4.6B
| $717K | ﹤0.01% |
27,750
+4,400
| +19% | +$116K |
|
|
RYL
1798
DELISTED
RYLAND GROUP INC
RYL
| $716K | ﹤0.01% |
17,546
| – | – |
|
|
LNCE
1799
DELISTED
Snyders-Lance, Inc.
LNCE
| $715K | ﹤0.01% |
21,210
+2,300
| +12% | +$76.9K |
|
1800
First Merchants
FRME
$2.72B
| $714K | ﹤0.01% |
27,238
+4,300
| +19% | +$111K |
|
Similar funds
T. Rowe Price Associates's Q3 2015 Portfolio in Review
As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
- T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
- T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
- T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
- T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
- T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.
Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.